St. Jude Research shared on X:
“New research by Thirumala-Devi Kanneganti in Cell reveals NLRC5 acts as an innate immune sensor and cell death regulator.
This understanding has therapeutic implications for treating cancers, infectious diseases and inflammatory disorders.”
Additional information.
Source: St. Jude Research/X